Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Stastna D, Menkyova I, Drahota J, Mazouchova A, Adamkova J, Ampapa R, Grunermelova M, Peterka M, Recmanova E, Rockova P, Rous M, Stetkarova I, Valis M, Vachova M, Woznicova I, Horakova D. Stastna D, et al. Among authors: woznicova i. Mult Scler Relat Disord. 2021 Sep;54:103104. doi: 10.1016/j.msard.2021.103104. Epub 2021 Jun 24. Mult Scler Relat Disord. 2021. PMID: 34216998 Free PMC article.
Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic.
Hradilek P, Meluzinova E, Zapletalova O, Hanulikova P, Horakova D, Woznicova I, Pavliska L, Stetkarova I, Valis M, Stourac P, Adamkova J, Ampapa R, Vachova M, Mares J. Hradilek P, et al. Among authors: woznicova i. Mult Scler Relat Disord. 2022 Mar;59:103391. doi: 10.1016/j.msard.2021.103391. Epub 2021 Nov 28. Mult Scler Relat Disord. 2022. PMID: 35240415
Is breastfeeding in MS harmful or not? An answer from real-world Czech data.
Hradilek P, Zapletalova O, Hanulikova P, Havrdova EK, Woznicova I, Mazouchova A, Drahota J, Lauer M, Stetkarova I, Valis M, Libertinova J, Stourac P, Adamkova J, Ampapa R, Vachova M, Dufek M, Martinková A, Peterka M, Recmanova E, Mares J, Horakova D. Hradilek P, et al. Among authors: woznicova i. Mult Scler Relat Disord. 2023 Aug;76:104790. doi: 10.1016/j.msard.2023.104790. Epub 2023 Jun 16. Mult Scler Relat Disord. 2023. PMID: 37348317
Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG.
Zeman D, Hradilek P, Kusnierova P, Piza R, Reguliova K, Woznicova I, Zapletalova O. Zeman D, et al. Among authors: woznicova i. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Mar;159(1):104-13. doi: 10.5507/bp.2014.058. Epub 2014 Dec 5. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015. PMID: 25485529 Free article.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group. Confavreux C, et al. Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23. Lancet Neurol. 2014. PMID: 24461574 Clinical Trial.